Jasper Therapeutics, Inc. - Class A (JSPR) SEC filings
JSPR SEC filings moved a median of +0.27% by the close. JSPR SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the JSPR overview →
77 measured JSPR SEC filing events.
Where these JSPR SEC filings landedvs 77 measured JSPR SEC filing reactions
| Middle 50% of JSPR SEC filing reactions | -3.77% to +4.00% |
|---|---|
| Median reaction (to close) | +0.27% |
| Measured reactions | 77 |
Point-in-time · zero look-ahead
Half of the 77 JSPR SEC filing events with a measured close landed between -3.77% and +4.00%; 51% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Jasper Therapeutics, For: Oct 15 | SEC filing · Form 8-K | +3.16% | +8.59% | |
| Form S-3 Jasper Therapeutics, | SEC filing · Form S-3 | +3.16% | +8.59% | |
| Form PRE 14A Jasper Therapeutics, For: Oct 09 | SEC filing · Form PRE | +0.02% | -2.43% | |
| Form 8-K Jasper Therapeutics, For: Oct 07 | SEC filing · Form 8-K | -0.50% | +4.86% | |
| Form 8-K Jasper Therapeutics, For: Sep 30 | SEC filing · Form 8-K | -1.23% | +4.00% | |
| Form 8-K/A Jasper Therapeutics, For: Jul 16 | SEC filing · Form 8-K | -1.23% | +4.00% | |
| Form 8-K/A Jasper Therapeutics, For: Jul 16 | SEC filing · Form 8-K | -3.38% | -8.10% | |
| Form 8-K Jasper Therapeutics, For: Sep 23 | SEC filing · Form 8-K | -3.06% | -2.51% | |
| Form DEF 14A Jasper Therapeutics, For: Sep 30 | SEC filing · Form DEF | -0.21% | +1.99% | |
| Form 8-K Jasper Therapeutics, For: Aug 21 | SEC filing · Form 8-K | +1.20% | -1.03% | |
| Form PRE 14A Jasper Therapeutics, For: Aug 24 | SEC filing · Form PRE | -1.38% | +1.65% | |
| Form 10-Q Jasper Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.45% | -5.51% | |
| Form 8-K Jasper Therapeutics, For: Aug 14 | SEC filing · Form 8-K | +4.42% | +9.38% | |
| Form D Jasper Therapeutics, | SEC filing · Form D | -5.32% | -0.84% | |
| Form 8-K Jasper Therapeutics, For: Jul 31 | SEC filing · Form 8-K | +1.64% | +9.10% | |
| Form 8-K Jasper Therapeutics, For: Jul 31 | SEC filing · Form 8-K | -4.75% | +0.00% | |
| Form 8-K Jasper Therapeutics, For: Jul 16 | SEC filing · Form 8-K | -6.03% | +23.00% | |
| Form 8-K Jasper Therapeutics, For: Jul 16 | SEC filing · Form 8-K | -6.03% | +23.00% | |
| Form ARS Jasper Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.30% | -3.77% | |
| Form DEF 14A Jasper Therapeutics, For: Jul 31 | SEC filing · Form DEF | -1.30% | -3.77% | |
| Form DEFA14A Jasper Therapeutics, | SEC filing · Form DEFA14A | -1.30% | -3.77% | |
| Form 8-K Jasper Therapeutics, For: Jun 03 | SEC filing · Form 8-K | +2.29% | +4.10% | |
| Form 8-K Jasper Therapeutics, For: Jun 01 | SEC filing · Form 8-K | -0.01% | -34.86% | |
| Form 8-K Jasper Therapeutics, For: May 15 | SEC filing · Form 8-K | -1.13% | +2.61% | |
| Form 10-Q Jasper Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.11% | -7.20% | |
| Form 8-K Jasper Therapeutics, For: May 14 | SEC filing · Form 8-K | +0.11% | -7.20% | |
| Form 10-K/A Jasper Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.41% | -1.01% | |
| Form 10-K Jasper Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +3.62% | +2.44% | |
| Form 8-K Jasper Therapeutics, For: Mar 30 | SEC filing · Form 8-K | +3.62% | +2.44% | |
| Form 8-K Jasper Therapeutics, For: Jan 08 | SEC filing · Form 8-K | +2.14% | -11.23% | |
| Form 8-K Jasper Therapeutics, For: Jan 02 | SEC filing · Form 8-K | +2.14% | -11.23% | |
| Form 8-K Jasper Therapeutics, For: Dec 02 | SEC filing · Form 8-K | +6.78% | -26.17% | |
| Form 10-Q Jasper Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -3.11% | -7.77% | |
| Form 8-K Jasper Therapeutics, For: Nov 10 | SEC filing · Form 8-K | -3.11% | -7.77% | |
| Form 8-K Jasper Therapeutics, For: Sep 18 | SEC filing · Form 8-K | -0.34% | +1.60% | |
| Form 10-Q Jasper Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.68% | +4.12% | |
| Form 8-K Jasper Therapeutics, For: Aug 13 | SEC filing · Form 8-K | +1.68% | +4.12% | |
| Form 8-K Jasper Therapeutics, For: Jul 08 | SEC filing · Form 8-K | +1.00% | +26.90% | |
| Form 8-K Jasper Therapeutics, For: Jul 07 | SEC filing · Form 8-K | +6.52% | +32.17% | |
| Form 8-K Jasper Therapeutics, For: Jul 03 | SEC filing · Form 8-K | +6.52% | +32.17% | |
| Form 8-K Jasper Therapeutics, For: Jun 14 | SEC filing · Form 8-K | -3.42% | -6.17% | |
| Form ARS Jasper Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.00% | +1.83% | |
| Form DEF 14A Jasper Therapeutics, For: Jul 03 | SEC filing · Form DEF | +0.00% | +1.83% | |
| Form DEFA14A Jasper Therapeutics, | SEC filing · Form DEFA14A | +0.00% | +1.83% | |
| Form 10-Q Jasper Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.11% | -2.43% | |
| Form 8-K Jasper Therapeutics, For: May 12 | SEC filing · Form 8-K | -1.11% | -2.43% | |
| Form EFFECT Jasper Therapeutics, | SEC filing · Form EFFECT | +0.42% | +2.98% | |
| Form 8-K Jasper Therapeutics, For: Mar 14 | SEC filing · Form 8-K | +0.57% | +0.57% | |
| Form S-3 Jasper Therapeutics, | SEC filing · Form S-3 | +0.57% | +0.57% | |
| Form 10-K Jasper Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.32% | +4.22% | |
| Form 8-K Jasper Therapeutics, For: Feb 27 | SEC filing · Form 8-K | +0.87% | -1.22% | |
| Form 8-K Jasper Therapeutics, For: Jan 08 | SEC filing · Form 8-K | -4.31% | -20.02% | |
| Form 10-Q Jasper Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -2.89% | -3.61% | |
| Form 8-K Jasper Therapeutics, For: Nov 07 | SEC filing · Form 8-K | -2.89% | -3.61% | |
| Form 8-K Jasper Therapeutics, For: Oct 14 | SEC filing · Form 8-K | +3.07% | +9.99% | |
| Form 10-Q Jasper Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.17% | +10.04% | |
| Form 8-K Jasper Therapeutics, For: Jun 17 | SEC filing · Form 8-K | +0.83% | -4.92% | |
| Form 8-K Jasper Therapeutics, For: Jun 06 | SEC filing · Form 8-K | +0.00% | -1.11% | |
| Form S-8 Jasper Therapeutics, | SEC filing · Form S-8 | -0.74% | -1.88% | |
| Form S-8 POS Jasper Therapeutics, | SEC filing · Form S-8 | -0.74% | -1.88% | |
| Form 10-Q Jasper Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | -1.44% | |
| Form DEFA14A Jasper Therapeutics, | SEC filing · Form DEFA14A | +0.00% | +0.62% | |
| Form ARS Jasper Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.45% | +0.27% | |
| Form DEF 14A Jasper Therapeutics, For: Jun 06 | SEC filing · Form DEF | +0.20% | +0.99% | |
| Form DEFA14A Jasper Therapeutics, | SEC filing · Form DEFA14A | +0.49% | +0.76% | |
| Form 10-K Jasper Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.64% | +7.60% | |
| Form S-8 Jasper Therapeutics, | SEC filing · Form S-8 | -2.64% | +7.60% | |
| Form 8-K Jasper Therapeutics, For: Mar 04 | SEC filing · Form 8-K | -2.08% | -5.51% | |
| Form 8-K Jasper Therapeutics, For: Feb 06 | SEC filing · Form 8-K | +1.95% | +3.13% | |
| Form 8-K Jasper Therapeutics, For: Jan 03 | SEC filing · Form 8-K | +2.53% | +4.16% | |
| Form 8-K Jasper Therapeutics, For: Jan 02 | SEC filing · Form 8-K | -0.68% | -0.57% | |
| Form 8-K Jasper Therapeutics, For: Dec 15 | SEC filing · Form 8-K | +2.96% | +2.41% | |
| Form DEF 14A Jasper Therapeutics, For: Dec 15 | SEC filing · Form DEF | +0.78% | -0.62% | |
| Form 10-Q Jasper Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -11.49% | -9.41% | |
| Form 8-K Jasper Therapeutics, For: Nov 09 | SEC filing · Form 8-K | -11.49% | -9.41% | |
| Form PRE 14A Jasper Therapeutics, For: Nov 09 | SEC filing · Form PRE | -1.48% | -9.48% | |
| Form 8-K Jasper Therapeutics, For: Oct 30 | SEC filing · Form 8-K | +0.00% | -2.52% |
Keep exploring
More JSPR: earnings → · analyst actions → · JSPR overview →